Magnetic Resonance Imaging of Breast Cancer and Correlation with Prognostic Factors

References

• Schnall MD, Blume J, Bluemke DA, DeAngelis GA, DeBruhl N, Harms S, et al. Diagnostic architectural and dynamic features at breast MR imaging: multicenter study. Radiology 2006; 238: 42–53
   PubMed Web of Science ®Google Scholar
• Kuhl CK, Schmutzler RK, Leutner CC, Kempe S, Wardelmann E, Hocke A, et al. Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results. Radiology 2000; 215: 267–79
   PubMed Web of Science ®Google Scholar
• Szabo BK, Aspelin P, Kristoffersen Wiberg M, Tot T, Bone B. Invasive breast cancer: correlation of dynamic MR features with prognostic factors. Eur Radiol 2003; 13: 2423–35
   Google Scholar
• Fischer U, Kopka L, Brinck U, Korabiowska M, Schauer A, Grabbe E. Prognostic value of contrast-enhanced MR mammography in patients with breast cancer. Eur Radiol 1997; 7: 1002–5
   Google Scholar
• Orel SG, Schnall MD. MR imaging of the breast for the detection, diagnosis, and staging of breast cancer. Radiology 2001; 220: 13–30
   PubMed Web of Science ®Google Scholar
• Gilles R, Guinebretiere JM, Lucidarme O, Cluzel P, Janaud G, Finet JF, et al. Nonpalpable breast tumors: diagnosis with contrast-enhanced subtraction dynamic MR imaging. Radiology 1994; 191: 625–31
   PubMedGoogle Scholar
• Nunes LW, Schnall MD, Orel SG. Update of breast MR imaging architectural interpretation model. Radiology 2001; 219: 484–94
   PubMed Web of Science ®Google Scholar
• Kuhl CK, Mielcareck P, Klaschik S, Leutner C, Wardelmann E, Gieseke J, et al. Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions?. Radiology 1999; 211: 5–7
   Google Scholar
• Malich A, Fischer DR, Wurdinger S, Boettcher J, Marx C, Facius M, et al. Potential MRI interpretation model: differentiation of benign from malignant breast masses. Am J Roentgenol 2005; 185: 964–70
   PubMed Web of Science ®Google Scholar
• ACR BI-RADS®-MRI. First edition. American College of Radiology, 2003.
   Google Scholar
• Stomper PC, Herman S, Klippenstein DL, Winston JS, Edge SB, Arredondo MA, et al. Suspect breast lesions: findings at dynamic gadolinium-enhanced MR imaging correlated with mammographic and pathologic features. Radiology 1995; 197: 387–95
   PubMed Web of Science ®Google Scholar
• Matsubayashi R, Matsuo Y, Edakuni G, Satoh T, Tokunaga O, Kudo S. Breast masses with peripheral rim enhancement on dynamic contrast-enhanced MR images: correlation of MR findings with histologic features and expression of growth factors. Radiology 2000; 217: 841–8
   PubMed Web of Science ®Google Scholar
• Lee SH, Cho N, Kim SJ, Cha JH, Cho KS, Ko ES, et al. Correlation between high resolution dynamic MR features and prognostic factors in breast cancer. Korean J Radiol 2008; 9: 10–8
   Google Scholar
• Bone B, Aspelin P, Bronge L, Veress B. Contrast-enhanced MR imaging as a prognostic indicator of breast cancer. Acta Radiol 1998; 39: 279–84
   Web of Science ®Google Scholar
• Mussrakis S, Buckley DL, Horsman A. Dynamic MR imaging of invasive breast cancer: correlation with tumor grade and other histological factors. Br J Radiol 1997; 70: 446–51
   Google Scholar
• Jatoi I, Hilsenbeck SG, Clark GM, Osborne CK. Significance of axillary lymph node metastasis in primary breast cancer. J Clin Oncol 1999; 17: 2334–40
   PubMed Web of Science ®Google Scholar
• Yaghan R, Stanton PD, Robertson KW, Going JJ, Murray D, McArdle CS. Estrogen receptor status predicts local recurrence following breast conservation surgery for early breast cancer. Eur J Surg Oncol 1998; 24: 424–6
   Google Scholar
• Elston CW, Ellis IO, Pinder SE. Pathological prognostic factors in breast cancer. Crit Rev Oncol Hematol 1999; 31: 209–23
   PubMed Web of Science ®Google Scholar
• Levekin C, Ellis IO, Locker A, Robertson JF, Bell J, Nicholson R, et al. c-erbB2 oncoprotein expression in primary and advanced breast cancer. Br J Cancer 1991; 63: 439–43
   Google Scholar
• Ikeda O, Nishimura R, Miyayama H, Yasunaga T, Ozaki Y,  Tuji A, et al. Evaluation of tumor angiogenesis using dynamic enhanced magnetic resonance imaging: comparison of plasma vascular endothelia growth factor, hemodynamic, and pharmacokinetic parameters. Acta Radiol 2004; 45: 446–52
   Web of Science ®Google Scholar
• Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol 1999; 182: 311–22
   Google Scholar
• Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991; 19: 403–10
   PubMed Web of Science ®Google Scholar
• Buada LD, Murakami J, Murayama S, Hashiguchi N, Sakai S, Masuda K, et al. Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis. Radiology 1996; 200: 639–49
   Google Scholar
• Schnall MD. An overview of interpretation strategies for breast MR imaging. Magn Reson Imaging Clin N Am 2001; 9: 289–94
   PubMedGoogle Scholar